Zurcher Kantonalbank Zurich Cantonalbank Grows Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Key Points

• Zurcher Kantonalbank increased its holdings in The Cooper Companies, Inc. by 17.8% during the first quarter, now owning 45,727 shares valued at $3.857 million.
• The Cooper Companies reported a quarterly earnings per share of $0.96, exceeding estimates, with a revenue of $1 billion, which is 6.3% higher year-over-year.
• Equities analysts have mixed ratings on the stock, with target prices ranging from $90.00 to $118.00, translating to an average rating of "Moderate Buy" with a target price of $96.73.

Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 17.8% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 45,727 shares of the medical device company's stock after acquiring an additional 6,894 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank's holdings in Cooper Companies were worth $3,857,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of the business. Covestor Ltd lifted its holdings in Cooper Companies by 35.5% during the fourth quarter. Covestor Ltd now owns 458 shares of the medical device company's stock valued at $42,000 after purchasing an additional 120 shares in the last quarter. Shell Asset Management Co. raised its position in shares of Cooper Companies by 15.5% during the 4th quarter. Shell Asset Management Co. now owns 946 shares of the medical device company's stock worth $87,000 after purchasing an additional 127 shares during the last quarter. UMB Bank n.a. lifted its stake in Cooper Companies by 16.7% in the 1st quarter. UMB Bank n.a. now owns 902 shares of the medical device company's stock valued at $76,000 after buying an additional 129 shares in the last quarter. Axxcess Wealth Management LLC boosted its holdings in Cooper Companies by 1.9% in the 1st quarter. Axxcess Wealth Management LLC now owns 7,382 shares of the medical device company's stock worth $623,000 after buying an additional 140 shares during the last quarter. Finally, Mitchell & Pahl Private Wealth LLC increased its stake in Cooper Companies by 1.8% during the 1st quarter. Mitchell & Pahl Private Wealth LLC now owns 8,675 shares of the medical device company's stock worth $732,000 after buying an additional 157 shares in the last quarter. Hedge funds and other institutional investors own 24.39% of the company's stock.

Cooper Companies Price Performance

Cooper Companies stock opened at $70.69 on Friday. The company has a current ratio of 2.10, a quick ratio of 1.23 and a debt-to-equity ratio of 0.30. The company has a 50-day moving average price of $72.49 and a 200 day moving average price of $80.88. The Cooper Companies, Inc. has a 12-month low of $65.00 and a 12-month high of $112.38. The stock has a market cap of $14.14 billion, a P/E ratio of 34.32, a PEG ratio of 1.76 and a beta of 0.99.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its quarterly earnings results on Thursday, May 29th. The medical device company reported $0.96 earnings per share for the quarter, beating the consensus estimate of $0.93 by $0.03. The business had revenue of $1 billion during the quarter, compared to analysts' expectations of $995.12 million. Cooper Companies had a net margin of 10.39% and a return on equity of 9.60%. The business's revenue for the quarter was up 6.3% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.85 EPS. Sell-side analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on COO shares. Wells Fargo & Company decreased their target price on Cooper Companies from $118.00 to $93.00 and set an "overweight" rating on the stock in a research report on Friday, May 30th. Robert W. Baird decreased their price objective on Cooper Companies from $107.00 to $97.00 and set an "outperform" rating on the stock in a report on Friday, May 30th. BNP Paribas Exane raised shares of Cooper Companies from a "neutral" rating to an "outperform" rating and set a $92.00 target price for the company in a report on Tuesday, July 22nd. Mizuho reduced their target price on shares of Cooper Companies from $105.00 to $90.00 and set an "outperform" rating for the company in a research report on Wednesday, July 16th. Finally, UBS Group upgraded shares of Cooper Companies to a "buy" rating in a research report on Tuesday, June 17th. Three investment analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $96.73.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COO - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.